April 20, 2001

FOR: ZOLL Medical Corporation

INVESTOR CONTACT: A. Ernest Whiton
Chief Financial Officer
ZOLL Medical Corporation
(978) 421-9655

PRESS CONTACT: Robert Minicucci
Corporate Communications Manager
ZOLL Medical Corporation
+1 (978) 421-9832
rminicucci@zoll.com

FOR IMMEDIATE RELEASE

ZOLL Medical Announces Receipt of Canadian License

Wednesday, April 04, 2001 – Burlington, MA, April 20, 2001 - ZOLL Medical Corporation (Nasdaq: ZOLL), a manufacturer of non-invasive cardiac resuscitation devices, which provide pacing, and defibrillation, today announced that it had received a license from Health Canada for the M-Series platform of defibrillators/pacemakers/monitors. This license encompasses all current configurations of the M-Series, including ZOLL’s unique rectilinear Biphasic waveform, and accessories. Included in this license are additional diagnostic/monitoring parameters such as SpO2 , EtCO2, NIBP and 12 Lead ECG.

Richard A. Packer, President and Chief Executive Officer of ZOLL, noted, “We are pleased to have our Canadian license. We can now proceed forward with plans to increase our business in Canada. Our direct sales team combined with the superiority of our M-Series should allow us to continue to increase our market share in Canada.”

ZOLL Medical Corporation designs, manufactures and markets an integrated line of proprietary non-invasive resuscitation devices and disposable electrodes. Used by health care professionals to provide both types of cardiac resuscitation – pacing and defibrillation – these products are essential in the emergency treatment of cardiac arrest victims both inside and outside the hospital. ZOLL also designs and markets software, which automates collection and management of both clinical and non-clinical data for emergency medical service providers.

Certain statements contained in this press release, including statements regarding the anticipated development of the Company’s business, the intent, belief or current expectations of the Company, its directors or its officers, primarily with respect to the Company’s business model and future operating performance of the Company, including expectations regarding results in future periods, operating performance, contributions to results from new products, the Company’s ability to exploit growth opportunities in the EMS data management and pre-hospital market, and other statements contained herein regarding matters that are not historical facts, are “forward-looking” statements (as such term is defined in the Private Securities Litigation Reform Act of 1995).Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled “Risk Factors” in the Company’s Report on Form 10-Q filed on February 14, 2001, as well as uncertainties regarding the market, acceptance and profitability of the Company’s new products and the desire or ability of other parties to purchase the Company’s products.

News Room Resources

April 20, 2001

Related Info